SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-089612
Filing Date
2023-11-22
Accepted
2023-11-22 16:30:19
Documents
13
Period of Report
2023-11-21
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea188916-8k_intensity.htm   iXBRL 8-K 29189
2 SECOND AMENDED & RESTATED BYLAWS ea188916ex3-1_intensity.htm EX-3.1 206529
  Complete submission text file 0001213900-23-089612.txt   451782

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ints-20231121.xsd EX-101.SCH 3054
4 XBRL LABEL FILE ints-20231121_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ints-20231121_pre.xml EX-101.PRE 22385
7 EXTRACTED XBRL INSTANCE DOCUMENT ea188916-8k_intensity_htm.xml XML 3523
Mailing Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880
Business Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

IRS No.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41109 | Film No.: 231433883
SIC: 2836 Biological Products, (No Diagnostic Substances)